Schott Pharma AG & Co. KGaA Depositary Receipt logo

Schott Pharma AG & Co. KGaA Depositary Receipt (1SX)

Market Open
11 Aug, 20:00
XFRA XFRA
5. 25
-0.05
-0.9434%
- Market Cap
- P/E Ratio
0.21% Div Yield
100 Volume
- Eps
5.3
Previous Close
Add Transaction
Day Range
5.2 5.25
Year Range
3 6.2
Want to track 1SX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

1SX trading today lower at €5.25, a decrease of -0.9434% from yesterday's close, completing a monthly increase of 29.3103% or €1.19. Over the past 12 months, 1SX stock gained 47.4719%.
1SX pays dividends to its shareholders, with the most recent payment made on Feb 23, 2026. The next estimated payment will be in In 6 months on Feb 23, 2027 for a total of €0.05296.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).

1SX Chart

Schott Pharma AG & Co. KGaA Depositary Receipt (1SX) FAQ

What is the stock price today?

The current price is €5.25.

On which exchange is it traded?

Schott Pharma AG & Co. KGaA Depositary Receipt is listed on XFRA.

What is its stock symbol?

The ticker symbol is 1SX.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.21%.

What is its market cap?

As of today, no market cap data is available.

Has Schott Pharma AG & Co. KGaA Depositary Receipt ever had a stock split?

No, there has never been a stock split.

Schott Pharma AG & Co. KGaA Depositary Receipt Profile

- Industry
- Sector
Mr. Andreas Reisse CEO
XFRA Exchange
- ISIN
Germany Country
4,839 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Schott Pharma AG & Co. KGaA is a dedicated participant in the healthcare industry, focusing on the development and manufacturing of premium pharmaceutical packaging solutions. The company has gained recognition for producing an extensive array of primary packaging materials, including those made from both glass and polymers. These products are essential for safe and effective drug delivery and cater to a multitude of sectors, including pharmaceuticals, biotechnology, and diagnostics. Schott Pharma prioritizes innovation and sustainability, consistently investing in cutting-edge technologies to address the evolving demands of the healthcare field. This commitment not only enhances drug integrity and safety but also solidifies Schott Pharma's role in supporting the global healthcare infrastructure. As a member of the larger Schott Group, the company boasts deep industry expertise and an expansive product portfolio, making it a pivotal player in the pharmaceutical supply chain.

Products and Services

  • Syringes: Schott Pharma manufactures high-quality syringes designed for the precise and safe administration of medications. These syringes are engineered to ensure optimal performance and user safety, meeting stringent regulatory standards.
  • Vials: The company produces a wide variety of glass and polymer vials, which serve as reliable containers for pharmaceuticals. These vials are designed to protect the integrity of the drugs while providing easy access for healthcare providers.
  • Ampoules: Schott Pharma’s ampoules are crafted to ensure the highest level of protection for sensitive medications. Their robust design mitigates the risk of contamination, securing the contents until they are ready for use.
  • Cartridges: The cartridges offered by Schott Pharma are geared towards modern drug delivery systems. They are compatible with various delivery devices and optimized for seamless integration, ensuring effective dosing and minimal waste.
  • Innovation and Sustainability Initiatives: The company invests in advanced technologies and sustainable practices to enhance their product offerings. Their commitment to innovation ensures they remain at the forefront of the packaging industry, meeting the changing needs of healthcare professionals and patients alike.

Contact Information

Address: Hattenbergstrasse 10
Phone: 49 6131 66 0